Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Lancet. 2003 Jan 4;361(9351):45-6.

Autologous bone-marrow stem-cell transplantation for myocardial regeneration.

Author information

  • 1Department of Cardiac Surgery, University of Rostock, 18057, Rostock, Germany.

Abstract

Implantation of bone-marrow stem cells in the heart might be a new method to restore tissue viability after myocardial infarction. We injected up to 1.5x10(6) autologous AC133+ bone-marrow cells into the infarct border zone in six patients who had had a myocardial infarction and undergone coronary artery bypass grafting. 3-9 months after surgery, all patients were alive and well, global left-ventricular function was enhanced in four patients, and infarct tissue perfusion had improved strikingly in five patients. We believe that implantation of AC133+ stem cells to the heart is safe and might induce angiogenesis, thus improving perfusion of the infarcted myocardium. See Commentary page 11

Comment in

PMID:
12517467
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Write to the Help Desk